H Bliesath

1.2k total citations
32 papers, 1.0k citations indexed

About

H Bliesath is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, H Bliesath has authored 32 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 10 papers in Pediatrics, Perinatology and Child Health and 9 papers in Oncology. Recurrent topics in H Bliesath's work include Pharmacogenetics and Drug Metabolism (13 papers), Drug Transport and Resistance Mechanisms (9 papers) and Pharmaceutical studies and practices (8 papers). H Bliesath is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Drug Transport and Resistance Mechanisms (9 papers) and Pharmaceutical studies and practices (8 papers). H Bliesath collaborates with scholars based in Germany, United States and Switzerland. H Bliesath's co-authors include M. Hartmann, Reinhard Huber, W Wurst, V W Steinijans, Reinhold Lühmann, Martin Lefkowitz, Karl Zech, Gregory Ligozio, Richard A. Krause and Philip B. Miner and has published in prestigious journals such as Gastroenterology, Stroke and The American Journal of Gastroenterology.

In The Last Decade

H Bliesath

31 papers receiving 918 citations

Peers

H Bliesath

GASTR

SURGE

PRM

PHARM

PHYSI

J. A. H. Forrest United Kingdom

Savio Reddymasu United States

Catherine A. Howie United Kingdom

J.M. Piqué Spain

B. Joelsson Sweden

A. R. Cooke United States

P. Timothy Pollak Canada

L Sölvell Sweden

Hilli Sevelius United States

N. R. Peden United Kingdom

J. A. H. Forrest United Kingdom

H Bliesath

255 ×0.4

GASTR

394 ×0.8

SURGE

150 ×0.7

PRM

134 ×1.0

PHARM

63 ×0.6

PHYSI

Citations per year, relative to H Bliesath H Bliesath (= 1×) peers J. A. H. Forrest

Countries citing papers authored by H Bliesath

Since Specialization

Citations

This map shows the geographic impact of H Bliesath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Bliesath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Bliesath more than expected).

Fields of papers citing papers by H Bliesath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Bliesath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Bliesath. The network helps show where H Bliesath may publish in the future.

Co-authorship network of co-authors of H Bliesath

This figure shows the co-authorship network connecting the top 25 collaborators of H Bliesath. A scholar is included among the top collaborators of H Bliesath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Bliesath. H Bliesath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bauer, Martin, H Bliesath, Chiara Leuratti, et al.. (2010). Disposition and Metabolism of Ralfinamide, a Novel Na-Channel Blocker, in Healthy Male Volunteers. Pharmacology. 86(5-6). 297–305. 6 indexed citations

Ullmann, U., et al.. (2009). Relative bioavailability of imipramine (Tofranil) coated tablets in healthy volunteers. International Journal of Clinical Pharmacology and Therapeutics. 39(6). 271–6.

Morganroth, Joel, et al.. (2002). Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects. The American Journal of Gastroenterology. 97(9). 2321–2327. 54 indexed citations

Novick, J., Philip B. Miner, Richard A. Krause, et al.. (2002). A randomized, double‐blind, placebo‐controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Alimentary Pharmacology & Therapeutics. 16(11). 1877–1888. 240 indexed citations

Bliesath, H, et al.. (2001). [Monotherapy of Parkinson's disease with budipine. A double blind comparison with amantadine].. Fortschritte der Neurologie · Psychiatrie. 69(2). 86–9. 3 indexed citations

Huber, Reinhard, H Bliesath, M. Hartmann, et al.. (1998). Pantoprazole does not interact with the pharmacokinetics of carbamazepine.. PubMed. 36(10). 521–4. 16 indexed citations

Kaps, Manfred, et al.. (1997). Characteristics of Transcranial Doppler Signal Enhancement Using a Phospholipid-Containing Echocontrast Agent. Stroke. 28(5). 1006–1008. 6 indexed citations

Fuder, H., M. Hartmann, Wolfgang Timmer, et al.. (1996). Lack of pharmacodynamic and pharmacokinetic interaction between pantoprazole and phenprocoumon in man. European Journal of Clinical Pharmacology. 51(3-4). 277–281. 18 indexed citations

Gugler, R, M. Hartmann, Reinhard Huber, et al.. (1996). Lack of pharmacokinetic interaction of pantoprazole with diazepam in man. British Journal of Clinical Pharmacology. 42(2). 249–252. 33 indexed citations

10.

Bliesath, H, et al.. (1996). Pantoprazole does not interact with nifedipine in man under steady-state conditions.. PubMed. 34(1 Suppl). 51–5. 21 indexed citations

11.

Hartmann, M., et al.. (1996). Twenty‐four‐hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole.. Alimentary Pharmacology & Therapeutics. 10(3). 359–366. 76 indexed citations

12.

Bliesath, H, et al.. (1996). Lack of pharmacokinetic interaction between pantoprazole and diclofenac.. PubMed. 34(1 Suppl). 152–6. 23 indexed citations

13.

Steinijans, V W, Rebekah S. Huber, M. Hartmann, et al.. (1996). Lack of pantoprazole drug interactions in man: an updated review.. PubMed. 34(1 Suppl). 243–50. 61 indexed citations

14.

Huber, Reinhard, M. Hartmann, H Bliesath, et al.. (1996). Pharmacokinetics of pantoprazole in man.. PubMed. 34(1 Suppl). 185–16. 113 indexed citations

15.

Müller, F. O., Robert Schall, G. Groenewoud, et al.. (1995). No influence of pantoprazole on the pharmacokinetics of phenytoin.. PubMed. 33(1 Suppl). 304–5. 22 indexed citations

16.

Fuder, H., M. Hartmann, Wolfgang Timmer, et al.. (1995). Lack of pharmacokinetic and pharmacodynamic interaction of pantoprazole and phenprocoumon in man. Gastroenterology. 108(4). A86–A86. 1 indexed citations

17.

Bliesath, H, et al.. (1995). Lack of Influence of Pantoprazole on Cardiovascular Function in Healthy Volunteers. Clinical Drug Investigation. 9(2). 72–78. 4 indexed citations

18.

Belz, G. G., et al.. (1992). Differential effects of two dihydropyridine calcium antagonists in humans. Clinical Pharmacology & Therapeutics. 52(1). 68–79. 4 indexed citations

19.

Schulz, H.‐U., M. Hartmann, V W Steinijans, et al.. (1991). Lack of influence of pantoprazole on the disposition kinetics of theophylline in man.. PubMed. 29(1 Suppl). 369–7. 34 indexed citations

20.

Simon, Bernd, Peter Müller, H Bliesath, et al.. (1990). Single intravenous administration of the H⁺, K⁺‐ATPase inhibitor BY 1023/SK&F 96022—inhibition of pentagastrin‐stimulated gastric acid secretion and pharmacokinetics in man. Alimentary Pharmacology & Therapeutics. 4(3). 239–245. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact